Effect of external shielding for neutrons during radiotherapy for prostate cancer, considering the 2300 CD linear accelerator and voxel phantom

• Published in: Radiation physics and chemistry (Oxford, England : 1993) England : 1993), 2014-02, Vol.95, p.267-270
• Main Authors: Thalhofer, J.L., Roque, H.S., Rebello, W.F., Correa, S.A., Silva, A.X., Souza, E.M., Batita, D.V.S., Sandrini, E.S.
• Format: Article
• Language: English
• Subjects: MCNPX and phantom; Neutron; Radiotherapy; Shield
• ISSN: 0969-806X; 1879-0895
• DOI: 10.1016/j.radphyschem.2013.02.013

Photoneutron production occurs when high energy photons, greater than 6.7MeV, interact with linear accelerator head structures. In Brazil, the National Cancer Institute, one of the centers of reference in cancer treatment, uses radiation at 4 angles (0°, 90°, 180° and 270°) as treatment protocol for prostate cancer. With the objective of minimizing the dose deposited in the patient due to photoneutrons, this study simulated radiotherapy treatment using MCNPX, considering the most realistic environment; simulating the radiotherapy room, the Linac 2300 head, the MAX phantom and the treatment protocol with the accelerator operating at 18MV. In an attempt to reduce the dose deposited by photoneutrons, an external shielding was added to the Linac 2300. Results show that the equivalent dose due to photoneutrons deposited in the patient diminished. The biggest reduction was seen in bone structures, such as the tibia and fibula, and mandible, at approximately 75%. Besides that, organs such as the brain, pancreas, small intestine, lungs and thyroid revealed a reduction of approximately 60%. It can be concluded that the shielding developed by our research group is efficient in neutron shielding, reducing the dose for the patient, and thus, the risk of secondary cancer, and increasing patient survival rates. ► Effect of external shielding to neutron during prostate cancer. ► Linac 2300, external shielding, radiotherapy room and MAX phantom were simulated. ► The results equivalent dose due to the photoneutrons in organs of patients decreased. ► The greatest dose reduction was verified in bone structures, approximately 75%. ► The shielding developed is effective for neutrons, decreasing the dose in patients.